Global burden of liver cirrhosis 1990–2019 and 20 years forecast: results from the global burden of disease study 2019

References

• Pinzani M, Rosselli M, Zuckermann M. Liver cirrhosis. Best Pract Res Clin Gastroenterol. 2011;25 (2):1–34. doi: 10.1016/j.bpg.2011.02.009.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383 (9930):1749–1761. doi: 10.1016/S0140–6736(14)60121–5.
   PubMed Web of Science ®Google Scholar
• Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371 (9615):838–851. doi: 10.1016/s0140–6736(08)60383–9.
   PubMed Web of Science ®Google Scholar
• Mokdad AA, Lopez AD, Shahraz S, et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Med. 2014;12 (1):145. doi: 10.1186/s12916–014–0145–y.
   PubMedGoogle Scholar
• Digestive diseases in the United States: epidemiology and Impact. NIDDK; Bethesda, MD: 1994. NIH Publication No. 94–1447.
   Google Scholar
• National Center for Health Statistics. US Department of Health and Human Services, Centers for Disease Control and Prevention; Hyattsville, MD: 2005. Series 13.
   Google Scholar
• Li M, Wang ZQ, Zhang L, et al. Burden of cirrhosis and other chronic liver diseases caused by specific etiologies in China, 1990–2016: findings from the global burden of disease study 2016. Biomed Environ Sci. 2020;33 (1):1–10. doi: 10.3967/bes2020.001.
   PubMed Web of Science ®Google Scholar
• Collaborators, G.B.D.C. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2020;5 (3):245–266. doi: 10.1016/S2468–1253(19)30349–8.
   PubMed Web of Science ®Google Scholar
• Vos T, Lim SS, Abbafati C, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396 (10258):1204–1222. doi: 10.1016/S0140–6736(20)30925–9.
   PubMed Web of Science ®Google Scholar
• Golabi P, Paik JM, AlQahtani S, et al. Burden of non–alcoholic fatty liver disease in asia, the Middle east and North africa: data from global burden of disease 2009–2019. J Hepatol. 2021;75 (4):795–809. doi: 10.1016/j.jhep.2021.05.022.
   PubMed Web of Science ®Google Scholar
• Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70 (4):674–683. doi: 10.1016/j.jhep.2018.12.001.
   PubMed Web of Science ®Google Scholar
• Xiao S, Xie W, Zhang Y, et al. Changing epidemiology of cirrhosis from 2010 to 2019: results from the global burden disease study 2019. Ann Med. 2023;55 (2):2252326. doi: 10.1080/07853890.2023.2252326.
   PubMed Web of Science ®Google Scholar
• Tan D, Chan KE, Wong ZY, et al. Global epidemiology of cirrhosis: changing etiological basis and comparable burden of nonalcoholic steatohepatitis between males and females. Dig Dis. 2023;41 (6):900–912. doi: 10.1159/000533946.
   PubMedGoogle Scholar
• Yim SY, Kim JH. The epidemiology of hepatitis B virus infection in korea. Korean J Intern Med. 2019;34 (5):945–953. doi: 10.3904/kjim.2019.007.
   PubMed Web of Science ®Google Scholar
• Collaborators, G.B.D.H.B. Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7 (9):796–829. doi: 10.1016/S2468–1253(22)00124–8.
   Google Scholar
• Wiktor SZ. Viral hepatitis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, Editors. Major infectious diseases. Washington (DC): The International Bank for Reconstruction and Development/The World Bank© 2017 International Bank for Reconstruction and Development/The World Bank., 2017.
   Google Scholar
• Lan Y, Wang H, Weng H, et al. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2019. Hepatol Commun. 2023;7 (2):e0026–e0026–e0026. doi: 10.1097/hc9.0000000000000026.
   Web of Science ®Google Scholar
• Huang P, Zhu LG, Zhu YF, et al. Seroepidemiology of hepatitis B virus infection and impact of vaccination. World J Gastroenterol. 2015;21 (25):7842–7850. doi: 10.3748/wjg.v21.i25.7842.
   PubMed Web of Science ®Google Scholar
• Ouyang G, Pan G, Guan L, et al. Incidence trends of acute viral hepatitis caused by four viral etiologies between 1990 and 2019 at the global, regional and national levels. Liver Int. 2022;42 (12):2662–2673. doi: 10.1111/liv.15452.
   PubMed Web of Science ®Google Scholar
• Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta–analysis. Lancet Gastroenterol Hepatol. 2022;7 (9):851–861. doi: 10.1016/s2468–1253(22)00165–0.
   PubMed Web of Science ®Google Scholar
• Kabbany MN, Conjeevaram Selvakumar PK, Watt K, et al. Prevalence of nonalcoholic Steatohepatitis–Associated cirrhosis in the United States: an analysis of national health and nutrition examination survey data. Am J Gastroenterol. 2017;112 (4):581–587. doi: 10.1038/ajg.2017.5.
   PubMed Web of Science ®Google Scholar
• Ye F, Zhai M, Long J, et al. The burden of liver cirrhosis in mortality: results from the global burden of disease study. Front Public Health. 2022;10:909455. doi: 10.3389/fpubh.2022.909455.
   PubMed Web of Science ®Google Scholar
• Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377 (21):2063–2072. doi: 10.1056/NEJMra1503519.
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease–Meta–analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64 (1):73–84. doi: 10.1002/hep.28431.
   PubMed Web of Science ®Google Scholar
• Huang DQ, Singal AG, Kono Y, et al. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34 (7):969–977 e2. doi: 10.1016/j.cmet.2022.05.003.
   PubMed Web of Science ®Google Scholar
• Lazarus JV, Mark HE, Anstee QM, et al. Advancing the global public health agenda for NAFLD: a consensus statement. Nat Rev Gastroenterol Hepatol. 2022;19 (1):60–78. doi: 10.1038/s41575–021–00523–4.
   PubMed Web of Science ®Google Scholar
• Karlsen TH, Sheron N, Zelber–Sagi S, et al. The EASL–Lancet liver commission: protecting the next generation of europeans against liver disease complications and premature mortality. Lancet. 2022;399 (10319):61–116. doi: 10.1016/S0140–6736(21)01701–3.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang X, Liu M, et al. Global, regional, and national burden of cirrhosis and other chronic liver diseases due to alcohol use, 1990–2019: a systematic analysis for the global burden of disease study 2019. BMC Gastroenterol. 2022;22 (1):484. doi: 10.1186/s12876–022–02518–0.
   PubMed Web of Science ®Google Scholar
• Shield K, Manthey J, Rylett M, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5 (1):e51–e61. doi: 10.1016/S2468–2667(19)30231–2.
   PubMed Web of Science ®Google Scholar
• Collaborators GBDA. Population–level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the global burden of disease study 2020. Lancet. 2022;400 (10347):185–235. doi: 10.1016/S0140–6736(22)00847–9.
   PubMed Web of Science ®Google Scholar
• Paik J, Henry L, Younossi Y, et al. The global burden of liver cancer (LC) and chronic liver diseases (CLD) is driven by non–alcoholic steatohepatitis (NASH) and alcohol liver disease (ALD). Journal of Hepatology. 2022;77: s 5–S7. doi: 10.1016/s0168–8278(22)00435–4.
   Google Scholar
• Suryaprasad AG, White JZ, Xu F, et al. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006–2012. Clin Infect Dis. 2014;59 (10):1411–1419. doi: 10.1093/cid/ciu643.
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Health Financing Collaborator, N. Past, present, and future of global health financing: a review of development assistance, government, out–of–pocket, and other private spending on health for 195 countries, 1995–2050. Lancet. 2019;393 (10187):2233–2260. doi: 10.1016/S0140–6736(19)30841–4.
   PubMed Web of Science ®Google Scholar
• Gorgani F, Esfahani Z, Ghamari SH, et al. Global, regional, and national burden and quality of care index of liver cirrhosis by cause from global burden of disease 1990–2019. J Gastroenterol Hepatol. 2023;38 (1):119–128. doi: 10.1111/jgh.16041.
   PubMed Web of Science ®Google Scholar
• Manthey J, Shield KD, Rylett M, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393 (10190):2493–2502. doi: 10.1016/s0140–6736(18)32744–2.
   PubMed Web of Science ®Google Scholar
• Liangpunsakul S, Haber P, McCaughan GW. Alcoholic liver disease in asia, Europe, and North America. Gastroenterology. 2016;150 (8):1786–1797. doi: 10.1053/j.gastro.2016.02.043.
   PubMed Web of Science ®Google Scholar
• Griswold MG, Fullman N, Hawley C, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2018;392 (10152):1015–1035. doi: 10.1016/S0140–6736(18)31310–2.
   PubMed Web of Science ®Google Scholar
• Murray CJL, Callender CSKH, Kulikoff XR, et al. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392 (10159):1995–2051. doi: 10.1016/S0140–6736(18)32278–5.
   PubMed Web of Science ®Google Scholar
• Moon AM, Singal AG, Tapper EB. Contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol Hepatol. 2020;18 (12):2650–2666. doi: 10.1016/j.cgh.2019.07.060.
   PubMed Web of Science ®Google Scholar
• Zhang T, Xu J, Ye L, et al. Age, gender and geographic differences in global health burden of cirrhosis and liver cancer due to nonalcoholic steatohepatitis. J Cancer. 2021;12 (10):2855–2865. doi: 10.7150/jca.52282.
   PubMed Web of Science ®Google Scholar
• Zacharakis GH, Koskinas J, Kotsiou S, et al. Natural history of chronic HBV infection: a cohort study with up to 12 years follow–up in North Greece (part of the interreg I–II/EC–project). J Med Virol. 2005;77 (2):173–179. doi: 10.1002/jmv.20434.
   PubMed Web of Science ®Google Scholar
• Di Martino V, Lebray P, Myers RP, et al. Progression of liver fibrosis in women infected with hepatitis C: long–term benefit of estrogen exposure. Hepatology. 2004;40 (6):1426–1433. doi: 10.1002/hep.20463.
   PubMed Web of Science ®Google Scholar
• Villa E, Karampatou A, Cammà C, et al. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology. 2011;140 (3):818–829.e2. doi: 10.1053/j.gastro.2010.12.027.
   PubMed Web of Science ®Google Scholar
• Codes L, Asselah T, Cazals–Hatem D, et al. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut. 2007;56 (3):390–395. doi: 10.1136/gut.2006.101931.
   PubMed Web of Science ®Google Scholar
• Yasuda M, Shimizu I, Shiba M, et al. Suppressive effects of estradiol on dimethylnitrosamine–induced fibrosis of the liver in rats. Hepatology. 1999;29 (3):719–727. doi: 10.1002/hep.510290307.
   PubMed Web of Science ®Google Scholar
• Coppola N, Alessio L, Onorato L, et al. Epidemiology and management of hepatitis C virus infections in immigrant populations. Infect Dis Poverty. 2019;8 (1):17. doi: 10.1186/s40249–019–0528–6.
   PubMedGoogle Scholar
• https://www.who.int/health–topics/refugee–and–migrant–health#tab=tab_1.
   Google Scholar
• Coppola N, Alessio L, Gualdieri L, et al. Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features. Infect Dis Poverty. 2017;6 (1):33. doi: 10.1186/s40249–016–0228–4.
   PubMedGoogle Scholar
• Sharma S, Carballo M, Feld JJ, et al. Immigration and viral hepatitis. J Hepatol. 2015;63 (2):515–522. doi: 10.1016/j.jhep.2015.04.026.
   PubMed Web of Science ®Google Scholar
• Pisaturo M, Alessio L, Starace M, et al. Characterization of hepatitis virus co–infections in a cohort of immigrants living in Southern Italy. J Med Virol. 2023;95 (3):e28665. doi: 10.1002/jmv.28665.
   PubMed Web of Science ®Google Scholar
• Mattlinger C, Thumfart JO, Heinen W[, et al. Hepatitis C virus seroprevalence and dependency on country of origin of refugees in Rhineland–Palatinate, Germany in 2015]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61 (11):1472–1480. doi: 10.1007/s00103–018–2816–x.
   PubMed Web of Science ®Google Scholar
• Coppola N, Alessio L, Gualdieri L, et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in undocumented migrants and refugees in Southern Italy, january 2012 to june 2013. Euro Surveill. 2015;20 (35):30009. doi: 10.2807/1560–7917.ES.2015.20.35.30009.
   PubMedGoogle Scholar
• Sayed N, Selzner N, Djerboua M, et al. Incidence of cirrhosis among recent immigrants and refugees to Ontario, Canada. Am J Gastroenterol. 2023;118 (7):1289–1292. doi: 10.14309/ajg.0000000000002214.
   PubMed Web of Science ®Google Scholar
• Gluud C. Mortality from cirrhosis: lack of progress over the last 35 years. Gut. 2005;54 (11):1523–1526. doi: 10.1136/gut.2005.072876.
   PubMed Web of Science ®Google Scholar